0001766157-25-000004.txt : 20250814
0001766157-25-000004.hdr.sgml : 20250814
20250814151910
ACCESSION NUMBER: 0001766157-25-000004
CONFORMED SUBMISSION TYPE: SCHEDULE 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20250814
DATE AS OF CHANGE: 20250814
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: PAVmed Inc.
CENTRAL INDEX KEY: 0001624326
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
EIN: 471214177
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-89489
FILM NUMBER: 251217968
BUSINESS ADDRESS:
STREET 1: 360 MADISON AVENUE
STREET 2: 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: (212) 949-4319
MAIL ADDRESS:
STREET 1: 360 MADISON AVENUE
STREET 2: 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: PAXmed Inc.
DATE OF NAME CHANGE: 20141105
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Sargent Investment Group, LLC
CENTRAL INDEX KEY: 0001766157
ORGANIZATION NAME:
EIN: 855082770
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
BUSINESS ADDRESS:
STREET 1: 4920 ELM STREET
STREET 2: SUITE 305
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: 2025806402
MAIL ADDRESS:
STREET 1: 4920 ELM STREET
STREET 2: SUITE 305
CITY: BETHESDA
STATE: MD
ZIP: 20814
SCHEDULE 13G
1
primary_doc.xml
SCHEDULE 13G
0001766157
XXXXXXXX
LIVE
Common
07/01/2025
0001624326
PAVmed Inc.
70387R403
360 MADISON AVENUE
25TH FLOOR
NEW YORK
NY
10017
Rule 13d-1(b)
Sargent Investment Group, LLC
MD
0.00
0.00
1006300.00
0.00
1006300.00
5.8
IA
PAVmed Inc.
360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NEW YORK, 10017
Sargent investment Group, LLC.
4920 Elm Street, Suite 305, Bethesda, Maryland 20814
Maryland, United States
N
IA
1006300
5.79%
0
1006300
1006300
0
Y
N
N
Other persons have the right to receive the proceeds from the sale of the securities reported herein.
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Sargent Investment Group, LLC
Kevin Kim
Compliance Officer
08/14/2025